Strategic Advocates’s Argan AGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$108K Sell
135
-27
-17% -$18K 0.42% 55
2026
Q1
$88.2K Sell
162
-1,124
-87% -$458K 0.39% 57
2025
Q4
$406K Sell
1,286
-64
-5% -$20.3K 0.1% 84
2025
Q3
$365K Buy
1,350
+62
+5% +$14.2K 0.09% 92
2025
Q2
$284K Buy
+1,288
New +$232K 0.08% 100

Other funds holding AGX

Strategic Advocates's AGX Position: Q2 2026 in Review

Strategic Advocates reduced its Argan (AGX) stake by 17% in Q2 2026, selling an estimated $18K and leaving 135 shares worth $108K. The position accounts for 0.42% of the portfolio, ranked #55.

Strategic Advocates first reported a position in AGX in Q2 2025 and has held it in 5 quarters since. The position peaked at $406K in Q4 2025. 564 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Strategic Advocates held 135 shares of Argan worth $108K as of Q2 2026.
  • Strategic Advocates sold 27 Argan shares in Q2 2026, an estimated $18K.
  • Argan made up 0.42% of Strategic Advocates's portfolio in Q2 2026, its #55 holding.
  • Strategic Advocates first reported a position in Argan in Q2 2025 and has held it in 5 quarters since.
  • Strategic Advocates's Argan position peaked at $406K in Q4 2025.
  • 564 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.